AstraZeneca SWOT Analysis, Competitors & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of AstraZeneca analyses the brand by its strengths, weaknesses, opportunities & threats. In AstraZeneca SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like AstraZeneca to benchmark its business & performance as compared to the competitors. AstraZeneca is one of the leading brands in the pharma and healthcare sector.

The table below lists the AstraZeneca SWOT (Strengths, Weaknesses, Opportunities, Threats), top AstraZeneca competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).

AstraZeneca SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
AstraZeneca Brand Analysis
Parent Company

AstraZeneca Biopharmaceuticals




Pharma and Healthcare

Tagline/ Slogan

Health connects us all


AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.

AstraZeneca STP

Cardiovascular, neuroscience, gastrointestinal, oncology, infection & respiratory diseases

Target Group

Healthcare professionals, doctors, hospitals offering treatments for above mentioned diseases


They are responsible for development of prescription medicines for six important areas of healthcare such as cancer, infection.

SWOT Analysis of AstraZeneca
AstraZeneca Strengths

Below are the Strengths in the SWOT Analysis of AstraZeneca:

1. Rapid decision making & streamlined due diligence processing

2. Good commercial and R&D presence in emerging markets

3. Active in over 100 countries employing over 60,000 people

4. High investment in R&D with 11,000+ dedicated R&D team

5. Ten products with global sales above 1 billion dollar
6. Product portfolio includes cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation medicines


Here are the weaknesses in the AstraZeneca SWOT Analysis:

1. It was affected by drug shortage crisis as in case of Cefotan

2. Product discontinuation affects the performance

3. Legal proceedings related to patents and pricing issues affect image

AstraZeneca Opportunities

Following are the Opportunities in AstraZeneca SWOT Analysis:

1. It can leverage its strong presence in emerging markets

2. Increasing importance of biosimiler market

3. Increasing global ageing population

AstraZeneca Threats

The threats in the SWOT Analysis of AstraZeneca are as mentioned:

1. Seroquel  their blockbuster drug is facing threat of copycat generic drugs

2. Stringent drug development guidelines
3. Competition coming up with effective drugs

AstraZeneca Competition
AstraZeneca Competitors

Below are the top 4 competitors of AstraZeneca:

1. Amgen
2. Genentech

3. Teva Pharmaceuticals

4. GlaxoSmithKline

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to AstraZeneca. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.

Continue Reading:

The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin